Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery
暂无分享,去创建一个
Jérôme Alexandre Denis | F. Coulet | A. Larsen | D. Pépin | Annette K Larsen | J. Wechsler | Gilles Manceau | Naoual Benali-Furet | Janine Wechsler | J. Denis | Maguy Bernard | Florence Coulet | J. Lacorte | G. Manceau | Alexia Patroni | Erell Guillerm | Dominique Pépin | Mehdi Karoui | Jean-Marc Lacorte | M. Bernard | M. Karoui | E. Guillerm | N. Benali-Furet | A. Patroni
[1] C. Punt,et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] Mef Nilbert,et al. The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis , 2014, Acta oncologica.
[3] Sridhar Ramaswamy,et al. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.
[4] Leon W M M Terstappen,et al. Challenges in circulating tumor cell detection by the CellSearch system , 2016, Molecular oncology.
[5] Steven J. M. Jones,et al. Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.
[6] Daniel J. Freeman,et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Jian-Bing Fan,et al. Accessing Genetic Information with Liquid Biopsies. , 2015, Trends in genetics : TIG.
[8] H. Koeppen,et al. Application of COLD-PCR for improved detection of KRAS mutations in clinical samples , 2009, Modern Pathology.
[9] Benjamin Thierry,et al. Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer—20 Years of Progress , 2015, Molecular medicine.
[10] Klaus Pantel,et al. Biology, detection, and clinical implications of circulating tumor cells , 2014, EMBO molecular medicine.
[11] E. Lianidou. Molecular Characterization of Circulating Tumor Cells: Holy Grail for Personalized Cancer Treatment? Editorial , 2022 .
[12] J. Rasko,et al. Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer. , 2014, Cancer letters.
[13] W. Gianni,et al. Circulating tumor cells in high-risk nonmetastatic colorectal cancer , 2013, Tumor Biology.
[14] N. Bird,et al. Biology of colorectal liver metastases: A review , 2006, Journal of surgical oncology.
[15] G. Barrière,et al. Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulations. , 2014, Annals of translational medicine.
[16] Tony Shen,et al. Clinical applications of next generation sequencing in cancer: from panels, to exomes, to genomes , 2015, Front. Genet..
[17] Jaw-Yuan Wang,et al. Detection of KRAS Oncogene in Peripheral Blood as a Predictor of the Response to Cetuximab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer , 2009, Clinical Cancer Research.
[18] N. Malats,et al. Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer , 2015, BMC Cancer.
[19] A. Bardelli,et al. Blood circulating tumor DNA for non‐invasive genotyping of colon cancer patients , 2016, Molecular oncology.
[20] Alexander Lorz,et al. Emergence of drug tolerance in cancer cell populations: an evolutionary outcome of selection, nongenetic instability, and stress-induced adaptation. , 2015, Cancer research.
[21] Michael Morse,et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] K. Pantel,et al. Technologies for detection of circulating tumor cells: facts and vision. , 2014, Lab on a chip.
[23] B. Lim,et al. Non‐invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients , 2015, Molecular oncology.
[24] K. Pantel,et al. Real-time liquid biopsy in cancer patients: fact or fiction? , 2013, Cancer research.
[25] A. Lièvre,et al. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] M. Gazouli,et al. Mutational Analysis of Circulating Tumor Cells from Colorectal Cancer Patients and Correlation with Primary Tumor Tissue , 2015, PloS one.
[27] Xianshu Gao,et al. "Liquid biopsy"-ctDNA detection with great potential and challenges. , 2015, Annals of translational medicine.
[28] J. Izbicki,et al. Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer. , 2013, Clinical chemistry.
[29] A. Lièvre,et al. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. , 2006, Cancer research.
[30] M R Speicher,et al. The biology of circulating tumor cells , 2016, Oncogene.
[31] M. Kitajima,et al. Clinical Significance of Circulating Tumor Cells in Blood from Patients with Gastrointestinal Cancers , 2008, Annals of Surgical Oncology.
[32] P. Laurent-Puig,et al. Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients. , 2013, Clinical chemistry.
[33] Jeff Mellen,et al. High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number , 2011, Analytical chemistry.
[34] I. Nagtegaal,et al. Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[35] C. Heeschen,et al. Circulating cancer stem cells: the importance to select. , 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.
[36] J. García-Foncillas,et al. KRAS mutational status analysis of peripheral blood isolated circulating tumor cells in metastatic colorectal patients , 2013, Oncology letters.
[37] Kathleen M Murphy,et al. Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications. , 2010, The Journal of molecular diagnostics : JMD.
[38] Allison Hills,et al. Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancer. , 2015, Clinical chemistry.
[39] P. Jänne,et al. A new device for rapid isolation by size and characterization of rare circulating tumor cells. , 2011, Anticancer research.
[40] S. Meijer,et al. The Perioperative Period is an Underutilized Window of Therapeutic Opportunity in Patients With Colorectal Cancer , 2009, Annals of surgery.
[41] Franck Molina,et al. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA , 2014, Nature Medicine.
[42] E. Lianidou,et al. The Role of CTCs as Tumor Biomarkers. , 2015, Advances in experimental medicine and biology.
[43] L. Frati,et al. Circulating Tumor Cells , 2012, Molecular Diagnosis & Therapy.
[44] E. Van Cutsem,et al. Mutant KRAS codon 12 and 13 alleles in patients with metastatic colorectal cancer: assessment as prognostic and predictive biomarkers of response to panitumumab. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] A. Jimeno,et al. KRAS mutation: comparison of testing methods and tissue sampling techniques in colon cancer. , 2010, The Journal of molecular diagnostics : JMD.
[46] S. Sleijfer,et al. KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue , 2013, International journal of cancer.
[47] Peter Ulz,et al. Circulating tumor DNA as a liquid biopsy for cancer. , 2015, Clinical chemistry.
[48] Hong Liu,et al. Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review. , 2015, Pathology, research and practice.
[49] R. Salgado,et al. Liquid biopsy: will it be the ‘magic tool’ for monitoring response of solid tumors to anticancer therapies? , 2015, Current opinion in oncology.
[50] R. Datar,et al. Size-based enrichment technologies for CTC detection and characterization. , 2012, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[51] A. Bardelli,et al. Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution. , 2014, Cancer discovery.
[52] F. Cianchi,et al. High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer. , 2008, American journal of clinical pathology.
[53] Christopher M. Hindson,et al. Absolute quantification by droplet digital PCR versus analog real-time PCR , 2013, Nature Methods.
[54] P. B. Lai,et al. Clinical Significance of Cytokeratin 20-Positive Circulating Tumor Cells Detected by a Refined Immunomagnetic Enrichment Assay in Colorectal Cancer Patients , 2009, Clinical Cancer Research.
[55] R. Chojniak,et al. Detection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer , 2015, Cancer biology & therapy.
[56] Bruno Landi,et al. Clinical Relevance of KRAS-Mutated Subclones Detected with Picodroplet Digital PCR in Advanced Colorectal Cancer Treated with Anti-EGFR Therapy , 2014, Clinical Cancer Research.
[57] E. Bonmassar,et al. Circulating tumor cells in colorectal cancer patients. , 2013, Cancer treatment reviews.
[58] Mo Chao Huang,et al. Microsieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells. , 2012, Lab on a chip.
[59] Johannes G. Reiter,et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers , 2012, Nature.
[60] J. Tabernero,et al. Molecular Predictors of Response to Chemotherapy in Colorectal Cancer , 2011, Cancer journal.
[61] I. Hudecova,et al. Digital PCR analysis of circulating nucleic acids. , 2015, Clinical biochemistry.
[62] G. Barrière,et al. Epithelial Mesenchymal Transition: A New Insight into the Detection of Circulating Tumor Cells , 2012, ISRN oncology.
[63] Bert Vogelstein,et al. DETECTION OF CIRCULATING TUMOR DNA IN EARLY AND LATE STAGE HUMAN MALIGNANCIES , 2014 .